| [1] |
Razumilava N, Gores J. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935):2168-2179.
|
| [2] |
邹晓平, 丁希伟. 肝门部胆管癌的诊治进展及展望[J]. 中华消化杂志, 2018, 38(3):151-154.
|
| [3] |
Groot Koerkamp B, Wiggers JK, Gonen M, et al. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram[J]. Ann Oncol, 2015, 26(9): 1930-1935.
|
| [4] |
Coelen RJ, Olthof PB, van Dieren S, et al. External validation of the estimation of physiologic ability and surgical stress (E-PASS) risk model to predict operative risk in perihilar cholangiocarcinoma[J]. JAMA Surg, 2016, 151(12):1132-1138.
|
| [5] |
Ruzzenente A, Bagante F, Ardito F, et al. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma[J]. Surgery, 2018, 164(2): 244-250.
|
| [6] |
Ding G, Yang Y, Cao L, et al. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma[J]. World J Surg Oncol, 2015(13):99.
|
| [7] |
Deoliveira ML, Schulick RD, Nimura Y, et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology, 2011, 53(4):1363-1371.
|
| [8] |
Wang Y, Fu W, Tang Z, et al. Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Medicine, 2018, 97(34):e12025.
|
| [9] |
田峰，赵鑫，崔劲驰，等. PTCD术前减黄在肝门部胆管癌半肝切除术中的应用 [J/CD]. 中华肝脏外科手术学电子杂志, 2018，7(4)：284-288.
|
| [10] |
Wiggers JK, Groot Koerkamp B, Coelen RJ, et al. Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage[J]. Endoscopy, 2015, 47(12):1124-1131.
|
| [11] |
Wiggers JK, Groot Koerkamp B, Cieslak KP, et al. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant[J]. J Am Coll Surg, 2016, 223(2): 321-331, e1.
|
| [12] |
Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J].J Gastroenterol, 2011, 46(2):242-248.
|
| [13] |
Zhang XF, Beal EW, Merath K, et al. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: percutaneous biliary drainage has no adverse effects on survival[J]. J Surg Oncol, 2018, 117(6):1267-1277.
|
| [14] |
Higuchi R, Yazawa T, Uemura S, et al. ENBD is associated with decreased tumor dissemination compared to PTBD in perihilar cholangiocarcinoma[J]. J Gastrointest Surg, 2017, 21(9):1506-1514.
|
| [15] |
Komaya K, Ebata T, Yokoyama Y, et al. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma[J]. Surgery, 2017, 161(2):394-404.
|
| [16] |
Rassam F, Roos E, van Lienden KP, et al. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience[J]. Langenbecks Arch Surg, 2018, 403(3):289-307.
|
| [17] |
Glantzounis GK, Tokidis E, Basourakos SP, et al. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. a systematic review[J]. Eur J Surg Oncol, 2017, 43(1):32-41.
|
| [18] |
Olthof PB, Wiggers JK, Groot Koerkamp B, et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization[J]. J Am Coll Surg, 2017, 225(3):387-394.
|
| [19] |
余璠，鲁正. 三维可视化技术在肝门部胆管癌术前评估中的应用[J]. 中国肿瘤临床, 2017, 44(8):390-394.
|
| [20] |
中华医学会数字医学分会, 中国研究型医院学会数字医学临床外科专业委员会. 肝门部胆管癌三维可视化精准诊治专家共识[J]. 中国实用外科杂志, 2017, 37(1):48-52.
|
| [21] |
Zeng N, Tao H, Fang C, et al. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type Ⅲ hilar cholangiocarcinoma[J]. World J Surg Oncol, 2016, 14(1):44.
|